Aquestive Therapeutics Cash Flow Statement (2017-2026)

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Operating Activities
Net Income (Quarter)	-14.55M	-28.95M	-13.22M	-16.30M	-12.54M	-12.35M	8.07M	-5.79M	-2.04M	-8.11M	-12.83M	-2.75M	-11.51M	-17.05M	-22.93M	-13.55M	-15.45M	-31.86M	-8.06M	-22.86M
Depreciation and Depletion (Quarter)	0.72M	0.72M	0.71M	0.66M	0.56M	0.34M	0.29M	0.25M	0.22M	0.39M	0.17M	0.17M	0.16M	0.15M	0.14M	0.14M	0.14M	0.13M	0.11M	0.14M
Share-based Compensation (Quarter)	5.12M	-5.11M			0.00M		0.01M	0.97M	0.77M	0.94M	0.89M	0.01M	3.80M	-3.60M	0.70M	2.77M	-2.68M	6.83M	2.32M	2.90M
Gains from Investment Securities (Quarter)
Asset Writedowns and Impairment (Quarter)
Cash from Operations (Quarter)	-9.06M	-8.06M	-14.48M	-6.56M	2.81M	8.42M	8.82M	-7.91M	-2.35M	-4.94M	-10.38M	-7.01M	-11.88M	-6.49M	-23.40M	-7.91M	-12.65M	-8.47M	-14.81M	-9.44M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
Amortization of Deferred Charges (Quarter)	1.17M	0.13M	0.04M	0.00M	0.00M	0.06M	0.22M	0.00M	0.00M	1.75M	2.67M	2.67M	2.67M	-7.78M	2.75M	-2.63M	0.06M	0.06M	2.29M	1.77M
Depreciation & Amortization (CF) (Quarter)	0.74M	0.73M	0.73M	0.67M	0.60M	0.40M	0.33M	0.29M	0.26M	0.47M	0.21M	0.20M	0.16M	0.15M	0.14M	0.14M	0.14M	0.13M	0.11M	0.14M
Change in Working Capital
Change in Receivables (Quarter)	1.33M	-1.37M	7.68M	-0.73M	-8.21M	-6.09M	2.22M	2.51M	-1.55M	-0.10M	-0.15M	-2.34M	3.71M	-2.32M	3.13M	1.35M	-0.06M	5.96M	-10.90M	2.46M
Change in Inventory (Quarter)	0.02M	1.18M	0.59M	0.38M	1.72M	-0.94M	1.20M	-1.03M	1.13M	-0.31M	0.96M	-0.77M	0.06M	-0.98M	1.15M	0.93M	-0.24M	-1.71M	1.90M	-0.71M
Change in Account Payables (Quarter)	-1.89M	2.10M	0.18M	0.39M	2.18M	-1.12M	2.49M	-1.75M	-0.69M	-1.07M	1.28M	-3.01M	1.88M	2.64M	1.91M	-0.32M	-1.31M	19.25M	-17.97M	-3.43M
Change in Accured Expenses (Quarter)	0.93M	1.20M	-3.96M	1.94M	-0.34M	-0.03M	-3.47M	-1.17M	1.17M	0.95M	-1.87M	0.13M	-0.66M	0.92M	-2.78M	0.60M	0.12M	5.09M	-2.80M	0.22M
Other Working Capital Changes (Quarter)
Investing Activities
Capital Expenditures (Quarter)	0.08M	0.53M	0.10M	0.68M	0.22M	0.03M	0.00M	0.83M	0.15M	-0.98M	0.03M	-0.03M		0.16M	0.14M	-0.05M	0.39M	-0.42M	0.05M	0.21M
Cash from Investing Activities (Quarter)	-0.08M	-0.53M	-0.10M	-0.68M	-1.72M	-0.03M	-0.00M	-0.83M	-0.15M	-0.02M	-0.03M	-0.04M	-0.08M	-0.01M	-0.14M	-0.11M	-0.23M	-0.09M	-0.05M	-0.21M
Financing Activities
Other financing activities (Quarter)		0.11M	1.30M	-1.28M	3.00M	-2.98M		12.54M	-12.51M	4.61M	0.01M	0.53M	-0.51M	0.04M		0.01M	0.01M	1.25M	0.00M	2.91M
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter)				3.81M			9.09M	-9.09M							0.01M				0.01M	54.33M
Change in Capital Stock
Shares Issued (Quarter)
Net Equity Issued and Repurchased (Quarter)
Misc.
Cash from Financing Activities (Quarter)	6.08M	5.45M	1.30M	10.20M	-0.14M	0.23M	-9.21M	4.29M	4.98M	3.91M	81.74M	1.71M	-0.02M	0.16M	20.65M	-0.10M	81.41M	0.66M	4.42M	-2.59M
Change in Cash (Quarter)	-3.07M	-3.14M	-13.29M	2.96M	0.95M	8.62M	-0.39M	-4.45M	2.48M	-1.04M	71.33M	-5.33M	-11.98M	-6.35M	-2.89M	-8.12M	68.53M	-7.89M	-10.44M	-12.24M
Free Cash Flow (Quarter)	-9.15M	-8.59M	-14.59M	-7.24M	2.59M	8.39M	8.81M	-8.73M	-2.50M	-3.96M	-10.41M	-6.98M	-11.88M	-6.65M	-23.54M	-7.86M	-13.04M	-8.04M	-14.86M	-9.65M
Net Cash Flow (Quarter)	-3.07M	-3.14M	-13.29M	2.96M	0.95M	8.62M	-0.39M	-4.45M	2.48M	-1.04M	71.33M	-5.33M	-11.98M	-6.35M	-2.89M	-8.12M	68.53M	-7.89M	-10.44M	-12.24M

Research Tools

Datasets

Plans

Developers

Aquestive Therapeutics AQST Cash Flow Statement (2017-2026)

Research Tools

Datasets

Plans

Developers

Aquestive Therapeutics AQST Cash Flow Statement (2017-2026)

Create an account

Sign In

Reset Password